Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuzo Hamamoto

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
In Vivo (Athens, Greece)|August 19, 2021
Modified Glasgow Prognostic Score 2 as a Prognostic Marker in Patients With Metastatic Urothelial CarcinomaTakashi Nagai, Taku Naiki, Teruki Isobe, et al.
Oncology|August 31, 2020
Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter AnalysisToshiki Etani, Taku Naiki, Yosuke Sugiyama, et al.
Diagnostics (Basel, Switzerland)|October 28, 2023
Postoperative Bladder Neck to Pubic Symphysis Ratio Predictive for De Novo Overactive Bladder after Robot-Assisted Radical ProstatectomyNayuka Matsuyama, Taku Naiki, Shuzo Hamamoto, et al.
Asian Journal of Endoscopic Surgery|January 30, 2026
Evaluation of the Safety of Robot-Assisted Radical Cystectomy for Bladder Cancer in OctogenariansToshiharu Morikawa, Shuzo Hamamoto, Yoshihiko Tasaki, et al.
BMC Research Notes|December 21, 2017
Complete remission of metastatic pheochromocytoma in <sup>123</sup>I-metaiodobenzylguanidine scintigraphy after a single session of <sup>131</sup>I-metaiodobenzylguanidine therapy: a case reportTeruaki Sugino, Ryosuke Ando, Rei Unno, et al.
Kidney International|April 6, 2020
Fatty acid-binding protein 4 downregulation drives calcification in the development of kidney stone diseaseKazumi Taguchi, Ling Chen, Manint Usawachintachit, et al.
Kidney & Blood Pressure Research|September 12, 2019
Active Phagocytosis and Diachronic Processing of Calcium Oxalate Monohydrate Crystals in an in vitro Macrophage ModelAtsushi Okada, Hiromasa Aoki, Daichi Onozato, et al.
Journal of Clinical Medicine|June 27, 2024
Efficacy and Safety of Immuno-Oncology Plus Tyrosine Kinase Inhibitors as Late-Line Combination Therapy for Patients with Advanced Renal Cell CarcinomaShuzo Hamamoto, Yoshihiko Tasaki, Toshiharu Morikawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 4, 2023
Clinical characteristics of Raoultella ornithinolytica bacteremia and antimicrobial susceptibility of RaoultellaornithinolyticaToshiki Etani, Shuhei Kondo, Takahiro Yanase, et al.
Biomedical Research (Tokyo, Japan)|June 5, 2024
Calcium phosphate controls nucleation and growth of calcium oxalate crystal phases in kidney stonesUta Michibata, Mihoko Maruyama, Yutaro Tanaka, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
In Vivo (Athens, Greece)|August 19, 2021
Modified Glasgow Prognostic Score 2 as a Prognostic Marker in Patients With Metastatic Urothelial CarcinomaTakashi Nagai, Taku Naiki, Teruki Isobe, et al.
Oncology|August 31, 2020
Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter AnalysisToshiki Etani, Taku Naiki, Yosuke Sugiyama, et al.
Diagnostics (Basel, Switzerland)|October 28, 2023
Postoperative Bladder Neck to Pubic Symphysis Ratio Predictive for De Novo Overactive Bladder after Robot-Assisted Radical ProstatectomyNayuka Matsuyama, Taku Naiki, Shuzo Hamamoto, et al.
Asian Journal of Endoscopic Surgery|January 30, 2026
Evaluation of the Safety of Robot-Assisted Radical Cystectomy for Bladder Cancer in OctogenariansToshiharu Morikawa, Shuzo Hamamoto, Yoshihiko Tasaki, et al.
BMC Research Notes|December 21, 2017
Complete remission of metastatic pheochromocytoma in <sup>123</sup>I-metaiodobenzylguanidine scintigraphy after a single session of <sup>131</sup>I-metaiodobenzylguanidine therapy: a case reportTeruaki Sugino, Ryosuke Ando, Rei Unno, et al.
Kidney International|April 6, 2020
Fatty acid-binding protein 4 downregulation drives calcification in the development of kidney stone diseaseKazumi Taguchi, Ling Chen, Manint Usawachintachit, et al.
Kidney & Blood Pressure Research|September 12, 2019
Active Phagocytosis and Diachronic Processing of Calcium Oxalate Monohydrate Crystals in an in vitro Macrophage ModelAtsushi Okada, Hiromasa Aoki, Daichi Onozato, et al.
Journal of Clinical Medicine|June 27, 2024
Efficacy and Safety of Immuno-Oncology Plus Tyrosine Kinase Inhibitors as Late-Line Combination Therapy for Patients with Advanced Renal Cell CarcinomaShuzo Hamamoto, Yoshihiko Tasaki, Toshiharu Morikawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 4, 2023
Clinical characteristics of Raoultella ornithinolytica bacteremia and antimicrobial susceptibility of RaoultellaornithinolyticaToshiki Etani, Shuhei Kondo, Takahiro Yanase, et al.
Biomedical Research (Tokyo, Japan)|June 5, 2024
Calcium phosphate controls nucleation and growth of calcium oxalate crystal phases in kidney stonesUta Michibata, Mihoko Maruyama, Yutaro Tanaka, et al.
Pageof 19